Search research articles
Contact Us
Filters
Showing results (411-420 of 498) with videos related to
Page
of 50
Sort By:
Radiology
|
June 1, 1997
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
F Moog, M Bangerter, C G Diederichs, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance
T Licht, K J Bross, H H Fiebig, et al.
The Journal of Pathology
|
August 9, 2005
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease
I Szanto, L Rubbia-Brandt, P Kiss, et al.
American Journal of Clinical Oncology
|
January 1, 1991
Clinical effects of recombinant human interleukin-3
A Ganser, A Lindemann, G Seipelt, et al.
European Journal of Biochemistry
|
December 15, 1993
Equine infectious anemia virus Tat is a predominantly helical protein
H Sticht, D Willbold, P Bayer, et al.
Molecular and Cellular Biology
|
July 1, 1996
The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins
R R Schumann, C J Kirschning, A Unbehaun, et al.
Endoscopy International Open
|
April 21, 2021
Functional endoscopy in neurogenic dysphagia: a feasibility study focusing on the esophageal phase of swallowing
Jan Rückert, Philipp Lenz, Hauke Heinzow, et al.
Blood
|
May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study
A Ganser, A Lindemann, O G Ottmann, et al.
Biotechnology Therapeutics
|
January 1, 1991
Results of phase I/II trials with recombinant human interleukin-3
A Ganser, O G Ottmann, G Seipelt, et al.
British Journal of Cancer
|
June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?
J Estève, L Parker, P Roy, et al.
Page
of 50
Search research articles
Search
Showing results (411-420 of 498) with videos related to
Sort By:
Page
of 50
Radiology
|
June 1, 1997
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
F Moog, M Bangerter, C G Diederichs, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance
T Licht, K J Bross, H H Fiebig, et al.
The Journal of Pathology
|
August 9, 2005
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease
I Szanto, L Rubbia-Brandt, P Kiss, et al.
American Journal of Clinical Oncology
|
January 1, 1991
Clinical effects of recombinant human interleukin-3
A Ganser, A Lindemann, G Seipelt, et al.
European Journal of Biochemistry
|
December 15, 1993
Equine infectious anemia virus Tat is a predominantly helical protein
H Sticht, D Willbold, P Bayer, et al.
Molecular and Cellular Biology
|
July 1, 1996
The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins
R R Schumann, C J Kirschning, A Unbehaun, et al.
Endoscopy International Open
|
April 21, 2021
Functional endoscopy in neurogenic dysphagia: a feasibility study focusing on the esophageal phase of swallowing
Jan Rückert, Philipp Lenz, Hauke Heinzow, et al.
Blood
|
May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study
A Ganser, A Lindemann, O G Ottmann, et al.
Biotechnology Therapeutics
|
January 1, 1991
Results of phase I/II trials with recombinant human interleukin-3
A Ganser, O G Ottmann, G Seipelt, et al.
British Journal of Cancer
|
June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?
J Estève, L Parker, P Roy, et al.
Page
of 50